Brunerova L, Smejkalova V, Potockova J, Andel M
Centre for Research of Diabetes, Metabolism and Nutrition and 2nd Department of Medicine of the 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic.
Diabet Med. 2007 May;24(5):533-40. doi: 10.1111/j.1464-5491.2007.02104.x. Epub 2007 Mar 22.
The aim of our study was to compare the influence of a hypocaloric, high-fat diet enriched with MUFA (M) and conventional diet (C) on weight loss and metabolic parameters in obese non-diabetic and obese Type 2 diabetic subjects over a 3-month period. It was our hypothesis that the enriched diet would be more effective in decreasing blood glucose and glycated haemoglobin (HbA(1c)) than the control diet.
Twenty-seven Type 2 diabetic patients (54.5 +/- 3.5 years; DM), treated with diet or oral glucose-lowering agents, and 31 obese non-diabetic subjects (53.6 +/- 3.5 years; OB) were randomized to M or C. Individual calculations of energy requirements were based on the formula: [resting energy expenditure (REE) x 1.5] - 600 kcal. Subjects were assessed by a dietitian every 2 weeks and by a physician every month. Statistical analyses were carried out between the four groups--DM/M, DM/C, OB/M and OB/C--using pair Student's test and anova.
After 3 months, body weight, waist-hip ratio, total body fat, levels of C-peptide, triglycerides and homeostasis model assessment (HOMA) decreased in all four groups (P < 0.01). However, fasting blood glucose and HbA(1c) decreased (P < 0.01) and high-density lipoprotein cholesterol increased significantly only in the DM/M group (P < 0.05). In general, M was well tolerated.
Individualized M and C diets were successful in improving metabolic and anthropometric parameters in both the obese non-diabetic and the Type 2 diabetic subjects. Although the superiority of the higher fat diet did not reach statistical significance, the decline in blood glucose and HbA(1c) in the Type 2 diabetic group on M was encouraging.
本研究旨在比较富含单不饱和脂肪酸(M)的低热量高脂饮食与传统饮食(C)对肥胖非糖尿病和肥胖2型糖尿病受试者在3个月期间体重减轻及代谢参数的影响。我们的假设是,这种强化饮食在降低血糖和糖化血红蛋白(HbA1c)方面比对照饮食更有效。
27例接受饮食或口服降糖药治疗的2型糖尿病患者(54.5±3.5岁;DM组)和31例肥胖非糖尿病受试者(53.6±3.5岁;OB组)被随机分为M组或C组。个体能量需求计算基于公式:[静息能量消耗(REE)×1.5]-600千卡。每2周由营养师对受试者进行评估,每月由医生进行评估。使用配对学生检验和方差分析在四组之间进行统计分析,这四组分别为DM/M组、DM/C组、OB/M组和OB/C组。
3个月后,所有四组的体重、腰臀比、全身脂肪、C肽水平、甘油三酯和稳态模型评估(HOMA)均下降(P<0.01)。然而,仅DM/M组的空腹血糖和HbA1c下降(P<0.01),高密度脂蛋白胆固醇显著升高(P<0.05)。总体而言,M组耐受性良好。
个体化的M饮食和C饮食成功改善了肥胖非糖尿病和2型糖尿病受试者的代谢及人体测量参数。尽管高脂肪饮食的优越性未达到统计学意义,但2型糖尿病组采用M饮食时血糖和HbA1c的下降令人鼓舞。